Merck Pushes To Sever Plaintiffs In Fosamax MDL
Merck & Co. Inc. urged a district court judge on Thursday to sever a dozen cases from an expansive multidistrict litigation over the osteoporosis drug Fosamax, while the plaintiffs countered that...To view the full article, register now.
Already a subscriber? Click here to view full article